XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
US Stock MarketDetailed Quotes
UCBJY UCB S.A. UNSP ADR EACH REPR 0.5 ORD
- 94.310
- -3.565-3.64%
15min DelayClose Feb 14 16:00 ET
35.78BMarket Cap147.82P/E (TTM)
96.260High94.310Low38.48KVolume96.250Open97.875Pre Close3.66MTurnover0.01%Turnover Ratio102.40P/E (Static)379.44MShares100.66052wk High3.85P/B35.78BFloat Cap50.22152wk Low0.73Dividend TTM379.44MShs Float100.660Historical High0.77%Div YieldTTM1.99%Amplitude31.963Historical Low95.053Avg Price1Lot Size
UCB S.A. UNSP ADR EACH REPR 0.5 ORD Stock Forum
Sign in to post a comment
Does anyone else think of investing in this way? See what good news might move the markets that day, invest in a bunch of companies, treat it like a portfolio. Trying this today with $Drug Manufacturers - General (LIST2428.US)$ stocks:
$Pfizer (PFE.US)$Plaxovid results against omicron may push it up
$EQRx (EQRX.US)$Meeting phase III endpoints for sugemabalib
$AstraZeneca (AZN.US)$Details of the HIMALAYA study showing 22% OS benefit in liver cancer
$UCB S.A. UNSP ADR EACH REPR 0.5 ORD (UCBJY.US)$Bimzelx achiev...
$Pfizer (PFE.US)$Plaxovid results against omicron may push it up
$EQRx (EQRX.US)$Meeting phase III endpoints for sugemabalib
$AstraZeneca (AZN.US)$Details of the HIMALAYA study showing 22% OS benefit in liver cancer
$UCB S.A. UNSP ADR EACH REPR 0.5 ORD (UCBJY.US)$Bimzelx achiev...
1
4
No comment yet
Trending Stocks
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve
Moo Earnings
Feb 2 12:39
AMZN earnings preview: Grab rewards by guessing the opening price!
bic mutney : buy more
Dafad OP : Might test the theory and see if it works… The market moves in mysterious ways, Cardiff Oncology (CRDF) had great data out yesterday and slumped, never quite know how markets take this kind of news (e.g. maybe people are looking at the data and thinking “well it’s good but it’s not great”)
Dafad OP : Eventually $Atara Biotherapeutics (ATRA.US)$ went up 2.08% but the worst was $EQRx (EQRX.US)$ going down 13.54%… Note to self - investigate why that would have been (strength of trial data? Competitive market for KRAS+ CRC? I.e. not so many people and actually quite a lot of drugs, and OS that’s not so special at 9months)
Evil_Monkey : You have to buy the rumor and sell the news. Once it hits the news, you should have already sold.